Vita Stack Health Review: What Its GLP-1 Documentation Establishes—and What It Does Not

A medication name is not a complete evidence package. For Vita Stack Health, the important distinction is between documentation of a telehealth service and proof of results from the particular treatment it delivers. The company advertises compounded semaglutide and tirzepatide, monthly clinician check-ins and pharmacy fulfillment. Those are meaningful service details, but they do not make clinical trial findings a performance report for this platform. This review examines what the public documentation supports, which claims remain company assertions and what a prospective patient would still need to confirm.

The pages consulted October 19, 2026 identify VitaStack LLC, a Delaware limited liability company, as the platform operator. They identify DrTelx as the independent clinical group and separate pharmacies as medication dispensers. That division matters: the platform does not itself make prescribing decisions. The documentation also includes promotional monthly prices, recurring billing terms and cancellation restrictions. Read together, these materials provide a useful description of the business, although they leave the precise formulation, supply quantity, individual price and several clinical-process details unresolved.

At a glance

Documented treatment offering: The GLP-1 program advertises compounded semaglutide or tirzepatide prescribed and monitored by an independent licensed provider; the consulted pages do not specify their administration routes.
Sources: [9]
Clinical responsibility: VitaStack LLC says it is not a medical practice and does not employ physicians or make clinical decisions. DrTelx is identified as the independent clinical provider network.
Sources: [10] [9]
Advertised monthly prices: Compounded semaglutide is advertised as low as $69 per month and compounded tirzepatide as low as $89 per month, subject to provider confirmation after a free online review and promotional availability.
Sources: [8]
Cancellation deadline: Cancellation through the portal or support email must be submitted at least 48 hours before the next billing date to avoid that charge; cancellation does not reverse existing medication orders.
Sources: [6]
Evidence boundary: Compounded preparations are not FDA approved or subject to FDA premarket review for safety, effectiveness and quality. That status alone does not demonstrate clinical inequivalence.
Sources: [1]

Start with the product, not the ingredient’s reputation

Vita Stack Health describes its weight-loss offering as compounded semaglutide or tirzepatide, prescribed and monitored within a broader care plan. Its pages also advertise injectable NAD+ for home administration and sermorelin when considered clinically appropriate. These additional offerings help describe the business, but their advertised energy, recovery, sleep or vitality benefits should not be mistaken for established outcomes. The company says all treatments require a prescription after evaluation and that not everyone will qualify.

For the GLP-1 products, an important documentation gap comes before any discussion of effectiveness: the consulted pages do not specify the administration route, exact presentation or quantity dispensed per monthly charge. Nor do they provide a provider-specific clinical outcomes study. A reader therefore cannot assume that the advertised preparation matches a product studied in a trial simply because the ingredient name is familiar. Our guide to formulation and route differences explains why those details belong in an evidence review.

FDA approval attaches to a specific product, not to a telehealth platform or a pharmacy. FDA says compounded preparations do not undergo its premarket review for safety, effectiveness and quality, and recommends them when an individual’s medical needs cannot be met by an approved drug. This is not a categorical finding that every compounded preparation is clinically inferior. It does mean that Vita Stack’s service description and a prescription alone cannot answer every product-evidence question.

Sources: [9] [1]

Separate company claims from independent verification

The platform identifies several organizations rather than presenting one business as responsible for everything. VitaStack LLC operates the technology and commercial service; DrTelx supplies independent clinicians who evaluate patients and issue prescriptions; pharmacies fill and ship medication. VitaStack explicitly says it is not a medical practice, does not employ physicians and does not make clinical decisions. This is useful disclosure, although naming the participants does not independently verify their licensing, credentials or performance.

The promotional page names EPIQ Scripts, Foothills Pharmacy and Emerald Compounding Pharmacy and describes them as licensed, PCAB-accredited U.S. compounding pharmacies. Elsewhere, the company makes broader network claims involving state licensure, NABP accreditation and LegitScript approval. VitaStack LLC also claims LegitScript certification. These are attributable company statements, not checks performed for this review. The consulted documentation does not explain how an individual patient’s pharmacy is selected or establish that every named pharmacy will serve every patient.

What each documented claim establishes
Public statement	What it supports	What remains unestablished
DrTelx conducts evaluations and prescribing	An identified clinical partner	Independent verification of each treating clinician
Named pharmacies fill and ship prescriptions	An identified fulfillment network	Which pharmacy handles a particular order
Pharmacy accreditation and licensing claims	The company’s stated credential standards	Independent verification in this review
Monthly provider check-ins	An advertised follow-up feature	A published protocol or measured outcomes
Compounded semaglutide or tirzepatide	The advertised medication category	Exact route, presentation and monthly quantity

Sources: [10] [9] [8]

Enrollment is documented more clearly than clinical timing

Access requires registration and an account with a username and password. The terms require users to be at least 18, have compatible technology and reside where services are available. The company advertises availability across all 50 states and Washington, D.C., while acknowledging that medication availability and consultation requirements vary. Its homepage lists live consultations before treatment in Washington, D.C., Kansas, Louisiana, Mississippi, New Mexico, Rhode Island and West Virginia. National coverage therefore does not mean identical service in every jurisdiction.

The initial process uses an encrypted health-history questionnaire within a secure patient platform. Vita Stack says most patients complete intake in under ten minutes, but that is not a promised clinician-review time. The homepage presents video consultation as a process step, while other documentation accommodates asynchronous care; a video visit should not be assumed for everyone. Full clinical admission criteria and required testing are not detailed in the consulted pages. Meeting the general account requirements does not guarantee care or a prescription.

Sources: [7] [8] [9]

Read the advertised price as a conditional offer

The promotional page advertises compounded semaglutide “as low as” $69 per month, alongside a previous advertised price of $299 per month. Compounded tirzepatide is advertised “as low as” $89 per month, alongside $349 per month previously. Both offers say a licensed provider confirms price after a free online review, and medication is supplied only if prescribed. The “Fall Sale ’26” promotion describes 250 limited places with “locked-in pricing,” but does not establish how long that lock lasts or what qualifies someone for the minimum price.

The promotional FAQ says the confirmed monthly price covers prescribed medication, free shipping and provider follow-up, with no hidden membership fees advertised. Nevertheless, the terms say the final charge may vary with medication and pharmacy, with support communicating differences. Vita Stack operates on a cash-pay basis; affiliated providers are not contracted with health insurance plans, including Medicare and Medicaid. The public documents do not establish monthly supply quantities, separate consultation prices, optional prepayment arrangements or prices for NAD+ and sermorelin.

These details support neither a universal $69 or $89 quote nor a conclusion that every listed feature costs extra. They support a narrower reading: the company publishes conditional package prices that require individual confirmation. Before authorizing recurring payment, a reader can request the exact medication presentation, quantity, billing date, confirmed recurring charge and any separately charged services. A monthly billing label is not, by itself, documentation of the amount of medication supplied or the duration of a treatment commitment.

Sources: [8] [7]

Follow-up promises need operational detail

The main program advertises monthly provider check-ins, care messaging available around the clock and dietitian visits subject to eligibility. Those features describe intended access, not measured clinical quality. The consulted pages do not fully explain dietitian eligibility, visit frequency or costs beyond the advertised inclusions. Nor does “24/7 care messaging” establish an immediate clinician response, a physician-only service or the administrative team’s hours. Asking who reviews messages and how urgent medication concerns are escalated would clarify the practical value of these features.

Administrative support publishes a different schedule: Monday through Friday, 9 a.m. to 6 p.m. Eastern, with replies within one to two business days at support@vitastackhealth.com. Separately, the privacy policy describes collection of medical history, medications, allergies, laboratory results and goals, and possible government-ID verification. It states that tracking technologies are not used on health-information entry pages or in the secure portal. These are documented privacy practices, not an independent security audit or proof that follow-up produces particular health outcomes.

Sources: [9] [6] [5]

Clinical research cannot fill the platform’s documentation gaps

STEP 1 and SURMOUNT-1 provide clinical research on specific studied semaglutide and tirzepatide regimens, respectively. Neither establishes outcomes for Vita Stack Health, its compounded preparations or an individual patient. They also do not justify a head-to-head ranking based on percentages from separate trials. Because Vita Stack’s consulted pages leave route and presentation unspecified, transferring research results directly to its advertised packages would skip an essential comparison. Our explanation of clinical trials versus company performance addresses that distinction.

The same discipline applies to safety claims. FDA reports medication-measurement and administration errors involving compounded products, including some associated with hospitalization, but such reports do not supply a Vita Stack-specific event rate. They are a reason to clarify instructions with the prescriber or pharmacist, not to calculate a dose from a review. Our guide to approved and compounded medicines separates regulatory status from clinical equivalence. NIDDK likewise frames medication selection around benefits, adverse effects, health conditions, other medicines and costs—not an ingredient name alone.

Sources: [3] [4] [1] [2]

Shipping claims stop short of a delivery guarantee

Vita Stack advertises discreet, fast shipping, and its promotional FAQ includes free shipping in the confirmed monthly package. Its policy says partner compounding pharmacies ship through tracked carriers. No firm clinical-review, preparation, dispatch or arrival deadline is established. The company asks patients to contact support when a shipment is more than seven business days beyond its expected delivery date; that is an investigation threshold, not a seven-day arrival promise. The policy also disclaims responsibility for specified carrier delays, incorrect addresses, failed delivery attempts and theft after confirmed delivery.

For damaged, incorrect or delivered-but-missing orders, the policy asks for contact within five business days of delivery. It describes working with the pharmacy on replacement or, if replacement is unavailable, a refund for affected items. If an injectable GLP-1 product arrives warm or inadequately refrigerated, FDA explicitly advises not using it and contacting the provider or dispensing pharmacy. That safety instruction is distinct from the company’s refund rules. Our guide to delivery and cold-chain claims explains why tracking alone cannot establish acceptable product condition.

Sources: [9] [8] [6] [1]

Cancellation and refunds have separate boundaries

The policy describes recurring subscription billing. Although advertising says “cancel anytime,” avoiding the next charge requires cancellation through the portal or support email at least 48 hours before the next billing date. Fees for a billing period already begun are nonrefundable, without partial-period refunds unless required by applicable law. Cancellation also does not cancel medication orders already placed or in transit. These distinctions matter because stopping future renewals is not the same as reversing a current charge, prescription order or shipment.

The documents generally make consultation fees nonrefundable and dispensed-and-shipped medication sales final. However, the refund policy allows discretionary review of a consultation fee after treatment denial if contacted within five business days, and provides the order-problem exception described above. Neither guarantees approval. Refund requests are reviewed within three to five business days; approved refunds are described as processed to the original payment method within five to ten business days, depending on the financial institution. Those statements should not be read as guaranteed bank-receipt dates.

Sources: [6] [7]

Questions & answers

Does Vita Stack Health prescribe medication itself?

The platform says it does not make clinical decisions or employ physicians. It identifies DrTelx as the independent medical group whose licensed providers evaluate patients and issue prescriptions. A prospective patient should distinguish the platform’s support role from the treating clinician’s responsibility. Enrollment, payment or completion of the questionnaire does not guarantee that the clinician will prescribe.

Sources: [10] [9] [7]

Are $69 and $89 guaranteed monthly treatment prices?

No. They are advertised minimum monthly prices for compounded semaglutide and compounded tirzepatide, respectively, with provider confirmation after a free review and limited promotional availability. The confirmed package is advertised to include medication, shipping and follow-up. The eligibility conditions for the minimum prices, duration of the promotional price lock and quantity supplied per charge are not established in the consulted pages.

Sources: [8]

Will every patient have a live video consultation?

That is not established. The homepage presents video consultation as a process step, but the documents also contemplate asynchronous care. The site specifically requires live consultations before treatment in Washington, D.C., Kansas, Louisiana, Mississippi, New Mexico, Rhode Island and West Virginia. Patients elsewhere should confirm the consultation format rather than assuming either video access or questionnaire-only prescribing.

Sources: [9] [7] [5]

Which pharmacy will fill my prescription?

The promotional page names EPIQ Scripts, Foothills Pharmacy and Emerald Compounding Pharmacy, but does not explain individual assignment. It attributes licensing and PCAB accreditation to those pharmacies; other pages make additional network credential claims. This review did not independently verify them. Ask for the dispensing pharmacy’s identity and contact information, along with the precise product presentation, before relying on a general description of the network.

Sources: [8] [9]

Can I use Medicare, Medicaid or private insurance?

Vita Stack’s terms describe cash-pay service and say affiliated medical providers are not contracted with any health insurance plans, including Medicare and Medicaid. The patient is responsible for service fees. This describes the platform’s payment arrangement; it does not establish whether a separate health plan covers other weight-management care or medications obtained elsewhere. Any outside coverage question requires confirmation with that plan.

Sources: [7] [2]

What should I do if I want to stop recurring charges?

Submit cancellation through the patient portal or support@vitastackhealth.com at least 48 hours before the next billing date. Retaining the request and confirmation is practical, especially because administrative replies are advertised within one to two business days. Cancellation does not automatically refund the current period or stop orders already placed or shipped. A treatment-denial refund request follows a separate discretionary process with a five-business-day contact window.

Sources: [6]

Our assessment

Vita Stack Health provides useful public detail about its operating company, clinical partner, named pharmacies, advertised follow-up and recurring-payment rules. It also openly identifies its GLP-1 offering as compounded medication and publishes conditional prices rather than withholding every cost figure. Those disclosures make the service more assessable, but they do not establish provider-specific effectiveness, independently verified credentials or a complete description of the product a patient would receive. The most consequential unresolved points are exact formulation and route, monthly supply quantity, individual recurring price, promotional duration, pharmacy assignment and clinical response arrangements. A sound next step is to obtain those details in writing and discuss the proposed compounded preparation with the treating clinician, including why it addresses needs an approved drug cannot meet. The documentation supports describing a GLP-1 telehealth service—not endorsing its outcomes or treating its marketing as clinical proof.

Visit Vita Stack Health’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Vita Stack Health Review: What Its GLP-1 Documentation Establishes—and What It Does Not

At a glance

01Start with the product, not the ingredient’s reputation

02Separate company claims from independent verification

03Enrollment is documented more clearly than clinical timing

04Read the advertised price as a conditional offer

05Follow-up promises need operational detail

06Clinical research cannot fill the platform’s documentation gaps

07Shipping claims stop short of a delivery guarantee

08Cancellation and refunds have separate boundaries